Brought to you by 
Meristem Therapeutics files, withdraws $46mm IPO
22 Jun 2022
Executive Summary
Meristem Therapeutics (proteins from plants) has filed for and since withdrawn an initial public offering on the Nouveau Marche of 2.28mm shares in the $18.80-$21.79 (Euro22-25.50) range. The company had hoped to raise about $46mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Technologies
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Meristem Therapeutics files, withdraws $46mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice